NEUROCRINE BIOSCIENCES INC awarded Chief Scientific Officer Onyia Jude 3,587 shares at $0 on September 11, 2026. The award lifted Jude’s reported holding to 24,583 shares, while a separate 1,936-share forfeiture at $156.22 left 22,647 shares, giving investors two distinct changes in the executive’s reported position.

Key Highlights

  • The award used transaction code A and represented about 14.6% of Jude’s resulting share holding.
  • Jude’s separate forfeiture used transaction code F and represented about 7.9% of the prior holding.
  • The reported holding after the award was 24,583 shares before the separate forfeiture entry.

NEUROCRINE BIOSCIENCES INC (NASDAQ: NBIX) awarded Chief Scientific Officer Onyia Jude 3,587 shares at $0 on September 11, 2026. Jude’s holding stood at 24,583 shares after that transaction, while a separate 1,936-share forfeiture at $156.22 per share left the reported holding at 22,647 shares.

$0 Award And $156.22 Forfeiture

The award was recorded under transaction code A. The separate forfeiture entry used transaction code F and was priced at $156.22 per share. Both transactions involved Jude, who serves as NEUROCRINE BIOSCIENCES INC’s Chief Scientific Officer. The two entries were dated September 11, 2026.

The award represented about 14.6% of Jude’s resulting share holding. The forfeiture represented about 7.9% of Jude’s prior share holding. The percentages use different reference points, with the award measured against the resulting position and the forfeiture measured against the position before that transaction. The transaction codes used here mean: A denotes an award, grant, or other Acquisition from the company; F denotes shares withheld or delivered to cover taxes or an exercise price.